Drug Screening to Target Nuclear Orphan Receptor NR4A2 for Cancer Therapeutics
Translational Lung Cancer Research - Hong Kong
doi 10.21037/tlcr.2017.07.02
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2017
Authors
Publisher
AME Publishing Company